Clinical Trials

{
  "url": "https://clinicaltrials.gov/study/NCT06767124",
  "title": "Supplementing Neuro-Energy to Aid Cognition",
  "nct_id": "NCT06767124",
  "phases": [
    "NA"
  ],
  "source": "clinicaltrials.gov",
  "status": "NOT_YET_RECRUITING",
  "conditions": [
    "Alzheimer Disease and Related Dementias (ADRD)"
  ],
  "enrollment": 17,
  "study_type": "INTERVENTIONAL",
  "lead_sponsor": "University of Pennsylvania",
  "published_at": "2026-07-28T00:00:00.000Z",
  "interventions": [
    {
      "name": "Ketogenic Supplement",
      "type": "DIETARY_SUPPLEMENT"
    },
    {
      "name": "Placebo Drink",
      "type": "OTHER"
    }
  ],
  "sponsor_class": "OTHER",
  "official_title": "Simultaneous PET/MR Imaging of Brain Glucose and Oxygen Metabolism to Assess Energy Deficits Related to Alzheimer's Disease and the Response to Intervention",
  "first_posted_at": "2025-01-09T00:00:00.000Z"
}

{
  "url": "https://clinicaltrials.gov/study/NCT00001456",
  "title": "Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome",
  "nct_id": "NCT00001456",
  "phases": [],
  "source": "clinicaltrials.gov",
  "status": "RECRUITING",
  "conditions": [
    "Hermansky-Pudlak Syndrome (HPS)"
  ],
  "enrollment": 600,
  "study_type": "OBSERVATIONAL",
  "lead_sponsor": "National Human Genome Research Institute (NHGRI)",
  "published_at": "2026-07-28T00:00:00.000Z",
  "interventions": [],
  "sponsor_class": "NIH",
  "official_title": "Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome",
  "first_posted_at": "1999-11-04T00:00:00.000Z"
}

{
  "url": "https://clinicaltrials.gov/study/NCT00756769",
  "title": "Systemic Lupus Erythematosus in Gullah Health",
  "nct_id": "NCT00756769",
  "phases": [],
  "source": "clinicaltrials.gov",
  "status": "RECRUITING",
  "conditions": [
    "Systemic Lupus Erythematosus"
  ],
  "enrollment": 750,
  "study_type": "OBSERVATIONAL",
  "lead_sponsor": "Medical University of South Carolina",
  "published_at": "2026-07-28T00:00:00.000Z",
  "interventions": [],
  "sponsor_class": "OTHER",
  "official_title": "Systemic Lupus Erythematosus in Gullah Health",
  "first_posted_at": "2008-09-22T00:00:00.000Z"
}

{
  "url": "https://clinicaltrials.gov/study/NCT07731854",
  "title": "Custom Provisionalisation",
  "nct_id": "NCT07731854",
  "phases": [
    "NA"
  ],
  "source": "clinicaltrials.gov",
  "status": "COMPLETED",
  "conditions": [
    "Tooth Loss and Rehabillitation"
  ],
  "enrollment": 36,
  "study_type": "INTERVENTIONAL",
  "lead_sponsor": "Universitaire Ziekenhuizen KU Leuven",
  "published_at": "2026-07-28T00:00:00.000Z",
  "interventions": [
    {
      "name": "Fully guided implant placement",
      "type": "PROCEDURE"
    },
    {
      "name": "Free handed implant placement",
      "type": "PROCEDURE"
    },
    {
      "name": "individualised abutment + digital prepared provisional crown",
      "type": "PROCEDURE"
    },
    {
      "name": "Provisional Cylinder + conventional provisional crown",
      "type": "PROCEDURE"
    }
  ],
  "sponsor_class": "OTHER",
  "official_title": "The Esthetic Outcome of Custom-Designed Profisionalisations of Immediate Implants in the Esthetic Zone: a Randomized, Controlled, Clinical Trial.",
  "first_posted_at": "2026-07-28T00:00:00.000Z"
}

{
  "url": "https://clinicaltrials.gov/study/NCT01036581",
  "title": "Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging",
  "nct_id": "NCT01036581",
  "phases": [
    "NA"
  ],
  "source": "clinicaltrials.gov",
  "status": "RECRUITING",
  "conditions": [
    "Drug Abuse",
    "Nicotine Dependence"
  ],
  "enrollment": 1000,
  "study_type": "INTERVENTIONAL",
  "lead_sponsor": "National Institute on Drug Abuse (NIDA)",
  "published_at": "2026-07-28T00:00:00.000Z",
  "interventions": [
    {
      "name": "MagPro X100 Magnetic Stimulator",
      "type": "DEVICE"
    },
    {
      "name": "Transcranial Rotating Magnetic Stimulator",
      "type": "DEVICE"
    },
    {
      "name": "Magnetom Prisma Fit 3T Scanner",
      "type": "DEVICE"
    }
  ],
  "sponsor_class": "NIH",
  "official_title": "Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging",
  "first_posted_at": "2009-12-21T00:00:00.000Z"
}

{
  "url": "https://clinicaltrials.gov/study/NCT07220811",
  "title": "Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy",
  "nct_id": "NCT07220811",
  "phases": [
    "PHASE2"
  ],
  "source": "clinicaltrials.gov",
  "status": "RECRUITING",
  "conditions": [
    "Ig-E Mediated Food Allergy"
  ],
  "enrollment": 100,
  "study_type": "INTERVENTIONAL",
  "lead_sponsor": "RAPT Therapeutics, Inc.",
  "published_at": "2026-07-28T00:00:00.000Z",
  "interventions": [
    {
      "name": "RPT904",
      "type": "DRUG"
    },
    {
      "name": "RPT904",
      "type": "DRUG"
    },
    {
      "name": "Placebo",
      "type": "OTHER"
    },
    {
      "name": "RPT904",
      "type": "DRUG"
    },
    {
      "name": "RPT904",
      "type": "DRUG"
    },
    {
      "name": "Placebo",
      "type": "OTHER"
    }
  ],
  "sponsor_class": "INDUSTRY",
  "official_title": "Phase 2b Randomized, Double-Blind, Placebo-Controlled Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy",
  "first_posted_at": "2025-10-24T00:00:00.000Z"
}

{
  "url": "https://clinicaltrials.gov/study/NCT07706764",
  "title": "A Study to Test the Effects and Safety of Palopegteriparatide in Adolescents With Long-term Hypoparathyroidism",
  "nct_id": "NCT07706764",
  "phases": [
    "PHASE3"
  ],
  "source": "clinicaltrials.gov",
  "status": "RECRUITING",
  "conditions": [
    "Hypoparathyroidism"
  ],
  "enrollment": 12,
  "study_type": "INTERVENTIONAL",
  "lead_sponsor": "Ascendis Pharma A/S",
  "published_at": "2026-07-28T00:00:00.000Z",
  "interventions": [
    {
      "name": "Palopegteriparatide",
      "type": "COMBINATION_PRODUCT"
    }
  ],
  "sponsor_class": "INDUSTRY",
  "official_title": "A Phase 3, Multicenter, Open-Label Single-Arm Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of Palopegteriparatide Administered Subcutaneously Daily in the Adolescent Population (12 Years to Less Than 18 Years of Age) With Chronic Hypoparathyroidism",
  "first_posted_at": "2026-07-16T00:00:00.000Z"
}

{
  "url": "https://clinicaltrials.gov/study/NCT05198830",
  "title": "Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer",
  "nct_id": "NCT05198830",
  "phases": [
    "PHASE2"
  ],
  "source": "clinicaltrials.gov",
  "status": "RECRUITING",
  "conditions": [
    "Lung Adenocarcinoma",
    "Lung Large Cell Carcinoma",
    "Lung Non-Squamous Non-Small Cell Carcinoma",
    "Stage III Lung Cancer AJCC v8"
  ],
  "enrollment": 42,
  "study_type": "INTERVENTIONAL",
  "lead_sponsor": "National Cancer Institute (NCI)",
  "published_at": "2026-07-28T00:00:00.000Z",
  "interventions": [
    {
      "name": "Carboplatin",
      "type": "DRUG"
    },
    {
      "name": "Cisplatin",
      "type": "DRUG"
    },
    {
      "name": "Computed Tomography",
      "type": "PROCEDURE"
    },
    {
      "name": "Durvalumab",
      "type": "BIOLOGICAL"
    },
    {
      "name": "FDG-Positron Emission Tomography",
      "type": "PROCEDURE"
    },
    {
      "name": "Magnetic Resonance Imaging",
      "type": "PROCEDURE"
    },
    {
      "name": "Methoxyamine",
      "type": "DRUG"
    },
    {
      "name": "Pemetrexed",
      "type": "DRUG"
    },
    {
      "name": "Radiation Therapy",
      "type": "RADIATION"
    }
  ],
  "sponsor_class": "NIH",
  "official_title": "A Phase 2 Randomized Study of the BER Inhibitor TRC102 in Combination With Standard Pemetrexed-Platinum-Radiation in Stage III Non-Squamous Non-Small Cell Lung Cancer",
  "first_posted_at": "2022-01-20T00:00:00.000Z"
}

{
  "url": "https://clinicaltrials.gov/study/NCT07618663",
  "title": "Personalized Meal Timing and Walking Based on Glucose Patterns in Adults With Prediabetes",
  "nct_id": "NCT07618663",
  "phases": [
    "NA"
  ],
  "source": "clinicaltrials.gov",
  "status": "COMPLETED",
  "conditions": [
    "Prediabetes",
    "Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)",
    "Prediabetes or Diabetes"
  ],
  "enrollment": 105,
  "study_type": "INTERVENTIONAL",
  "lead_sponsor": "Shifa International Hospital",
  "published_at": "2026-07-28T00:00:00.000Z",
  "interventions": [
    {
      "name": "Phenotype-Guided Meal Timing and Postprandial Walking",
      "type": "BEHAVIORAL"
    },
    {
      "name": "Sleep Hygiene and Step-Count Advice",
      "type": "BEHAVIORAL"
    }
  ],
  "sponsor_class": "OTHER",
  "official_title": "CGM-Phenotyped Circadian Glycemic Vulnerability Windows to Personalize Meal Timing and Postprandial Activity in Prediabetes : A Randomized Controlled Trial",
  "first_posted_at": "2026-06-01T00:00:00.000Z"
}

{
  "url": "https://clinicaltrials.gov/study/NCT07492498",
  "title": "Novel Model of Integrated Care of Older Patients With Atrial Fibrillation to Prevent Heart Failure in Rural China",
  "nct_id": "NCT07492498",
  "phases": [
    "NA"
  ],
  "source": "clinicaltrials.gov",
  "status": "RECRUITING",
  "conditions": [
    "Atrial Fibrillation",
    "Heart Failure"
  ],
  "enrollment": 1356,
  "study_type": "INTERVENTIONAL",
  "lead_sponsor": "Jiangsu Taizhou People's Hospital",
  "published_at": "2026-07-28T00:00:00.000Z",
  "interventions": [
    {
      "name": "Village-Doctor Led Integrated Care",
      "type": "OTHER"
    },
    {
      "name": "Usual Care",
      "type": "OTHER"
    }
  ],
  "sponsor_class": "OTHER",
  "official_title": "Novel Model of Integrated Care of Older Patients With Atrial Fibrillation to Prevent Heart Failure in Rural China",
  "first_posted_at": "2026-03-25T00:00:00.000Z"
}